Dr. Kalali is recognized globally as a leading innovator at the intersection of life sciences and technology, advising companies on building their future business at the board level or as a strategic advisor.

He is an advisor to the Center for Digital Transformation at the Paul Merage School of Business at UC Irvine, the premier research center helping leaders across industries take advantage of the new digital economy and a faculty member of the Singularity University and BART X medical education initiative.

Dr. Kalali is Professor of Psychiatry at UC San Diego, Editor of the Journal Innovations in Clinical Neuroscience, Lead Editor of the book Essential CNS Drug Development, and has authored over 150 peer-reviewed publications.

Previously, for almost 20 years, he was Global Head of the Neuroscience Center of Excellence at Quintiles, now known as IQVIA, where he was responsible for numerous successful drug development programs that have led to new treatments for patients.